检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Alemtuzumab provides durable improvements in clinical outcomes in treatment-naive patients with active relapsing-remitting multiple sclerosis over 6 years in the absence of continuous treatment (CARE-MS I).

Alasdair Coles,Alexey Boyko,Jeffrey A. Cohen,J. De Seze,Edward Fox,Eva Havrdova, H.-P. Hartung,Jihad Inshasi,Pamela A. McCombe,Krzysztof Selmaj,Patrick Vermersch,B. Van Wijmeersch,David Margolin,Karthinathan Thangavelu,C. E. Rodriguez,X. Montalban

MULTIPLE SCLEROSIS JOURNAL（2016）

引用 24|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要